UiPath Vs. Corcept Therapeutics Industry Stock Comparison

Sell

40

PATH
UiPath

Last Price:

12.45

Seasonality Move:

4.36%

Buy

68

CORT
Corcept Therapeutics

Last Price:

40.92

Seasonality Move:

-0.77%

Sell

40

UiPath (PATH) is a Sell

Is UiPath a Buy, Sell or Hold?

The current UiPath [PATH] share price is $12.30. The Score for PATH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

68

Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PATH Stock Price Chart

What is UiPath's stock price today?

The UiPath share price today is $12.30
The current trend is relatively stagnant and PATH is experiencing slight selling pressure.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.

PATH Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.04	Buy
Relative Strength Index (14 RSI):	50.57	Buy
Chaikin Money Flow:	-1963148	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11.94 - 12.68)	Sell
Bollinger Bands (100):	(10.63 - 17.03)	Sell

CORT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.36	Buy
Relative Strength Index (14 RSI):	82.3	Buy
Chaikin Money Flow:	670376	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(33.47 - 37.45)	Buy
Bollinger Bands (100):	(28.16 - 35.86)	Buy

PATH Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.23	Buy
20-day SMA:	12.42	Sell
50-day SMA:	12.11	Buy
200-day SMA:	18.5	Sell
8-day EMA:	12.31	Sell
20-day EMA:	12.28	Buy
50-day EMA:	12.56	Sell
200-day EMA:	15.95	Sell

CORT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.44	Buy
20-day SMA:	35.75	Buy
50-day SMA:	34.88	Buy
200-day SMA:	28.43	Buy
8-day EMA:	38.24	Buy
20-day EMA:	36.43	Buy
50-day EMA:	34.68	Buy
200-day EMA:	30.05	Buy

UiPath Earnings Growth & PATH Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.02 per share, an increase this year of $0.41 per share, and a decrease next year of $0.07 per share.

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.

UiPath Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):